Showing results (21-30 of 293) with videos related to
Sort By:
Pageof 30
Science Translational Medicine|September 27, 2019
Wrangling RNA: Antisense oligonucleotides for neurological disordersKevin Talbot, Matthew J A WoodTrends in Genetics : TIG|December 8, 2009
Therapeutic gene silencing strategies for polyglutamine disordersJanine Scholefield, Matthew J A WoodNature Reviews. Neurology|December 2, 2017
Antisense oligonucleotides: the next frontier for treatment of neurological disordersCarlo Rinaldi, Matthew J A WoodContact Dermatitis|December 1, 1995
Sensitization of mice to paraphenylenediamine and structurally-related compounds: adjuvant effects of vitamin A supplementationR S Kalish, J A WoodJournal of Neuromuscular Diseases|June 7, 2021
Emerging Oligonucleotide Therapeutics for Rare Neuromuscular DiseasesYoshitsugu Aoki, Matthew J A WoodThe Knee|December 8, 2004
Salvage revision total knee replacement using the Endo-Model rotating hinge prosthesisN R Pradhan, L Bale, P Kay, et al.Med (New York, N.Y.)|November 12, 2022
RNase-H-mediated silencing in the CNS proves predictably nontrivialMichael P Moazami, Matthew J A WoodPlos One|October 28, 2011
Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson's diseaseChristopher R Sibley, Matthew J A WoodHuman Molecular Genetics|March 20, 2009
Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeuticsMarc S Weinberg, Matthew J A WoodEssays in Biochemistry|July 9, 2013
Therapeutic targeting of non-coding RNAsThomas C Roberts, Matthew J A WoodPageof 30